26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

oral tolerance 543 Orthoclone OKT®3<br />

significant in periodontal disease. Individuals with immunodeficiencies<br />

often have increased mucosal infections by<br />

opportunistic microorganisms such as by Candida albicans.<br />

Immunopathologic mechanisms that involve types II, III, and<br />

IV hypersensitivity may be involved in the development and<br />

progression of chronic periodontitis. Vaccines may be used in<br />

the future to prevent or control dental caries and periodontal<br />

diseases. Oral or intranasal routes of vaccine administration<br />

may prove useful to protect against oral infections.<br />

oral tolerance<br />

Antigen-induced specific suppression of humoral and cellmediated<br />

immunity to an antigen following oral administration<br />

of that antigen as a consequence of anergy of<br />

antigen-specific T lymphocytes or the formation of immunosuppressive<br />

cytokines such as transforming growth factor<br />

β (TGF-β). Oral tolerance may inhibit immune responses<br />

against food antigens and bacteria in the intestine. Proteins<br />

passing through the gastrointestinal tract induce antigenspecific<br />

hyporesponsiveness. Oral tolerance is believed to<br />

have evolved to permit the gut-associated immune system to<br />

be exposed to external proteins without becoming sensitized.<br />

If proteins such as ovalbumin or myelin basic protein (MBP)<br />

are fed to animals that are then immunized, the immune<br />

response against the fed antigen, but not against the control<br />

antigen, is subsequently diminished. Based on the quantity<br />

of antigen fed, orally administered antigen may induce<br />

regulatory cells that suppress the antigen-specific response<br />

(low doses) or inhibit antigen-specific T cells by induction of<br />

clonal anergy (high doses). Antigens passing through the gastrointestinal<br />

tract preferentially induce T helper (Th2)-type<br />

T cells that secrete interleukin-4 (IL4), IL10, and TGF-β.<br />

oral unresponsiveness<br />

The selective ability of the mucosal immune system to react<br />

immunologically against antigens of food and intestinal<br />

microorganisms even though it responds vigorously to<br />

pathogenic microorganisms.<br />

organ bank<br />

A site where selected tissues for transplantation, such<br />

as acellular bone fragments, corneas, and bone marrow,<br />

may be stored for relatively long periods until needed.<br />

Several hospitals often share such a facility. Organs such<br />

as kidneys, liver, heart, lung, and pancreatic islets must be<br />

transplanted within 48 to 72 hours and are not suitable for<br />

storage in an organ bank.<br />

organ brokerage<br />

The selling of an organ such as a kidney from a living<br />

related donor to the transplant recipient is practiced in<br />

certain parts of the world but is considered unethical and is<br />

Oral tolerance.<br />

illegal in the United states because it violates the National<br />

Organ Transplant Act (Public Law 98-507, 3 USC).<br />

organ-specific antigen<br />

An antigen that is unique to a particular organ even though<br />

it may be found in more than one species.<br />

organ-specific autoimmune diseases<br />

Autoimmune reactivity against specific organs, such as the<br />

thyroid in Hashimoto’s thyroiditis, leads to cell and tissue<br />

damage to specific organs. By contrast, systemic lupus<br />

erythematosus (SLE) affects a wide variety of tissues and<br />

organs of the body.<br />

organ specific autoimmunity<br />

An autoimmune response directed against a specific anatomical<br />

site.<br />

organism-specific antibody index (OSAI)<br />

The ratio of organism-specific immunoglobulin G (IgG) to<br />

total IgG in cerebrospinal fluid (CSF) compared to the ratio<br />

of organism-specific IgG in serum to total serum IgG. This<br />

is illustrated in the following formula: an index >1 signifying<br />

a greater quantity of organism-specific immunoglobulin<br />

in CSF than in the blood serum implies that organismspecific<br />

IgG is being synthesized in the intra-blood–brain<br />

barrier (IBBB) and suggests that the specific organism of<br />

interest is producing an infection of the central nervous<br />

system. Similar indices can be calculated for IgM and IgA<br />

antibody classes.<br />

original antigenic sin<br />

When an individual is exposed to an antigen that is similar<br />

but not identical to an antigen to which he was previously<br />

exposed by infection or immunization, the immune<br />

response to the second exposure is still directed against<br />

the first antigen. This was first noticed in influenza virus<br />

infection. Due to antigenic drift and shift in influenza virus,<br />

reinfection with an antigenically altered strain generates<br />

a secondary immune response specific for the virus strain<br />

that produced an earlier infection. The antibody response<br />

against a second infection with influenza is restricted to<br />

epitopes that the second strain shares with the first strain<br />

that infected the host. Other highly immunogenic epitopes<br />

on second and subsequent viruses are ignored. B cell clones<br />

activated by an original antigen are reactivated in response<br />

to a new cross reactive antigen that possesses novel B cell<br />

epitopes in addition to T cell epitopes present on the original<br />

antigen.<br />

Orthoclone OKT ® 3<br />

A commercial antibody against the T cell surface marker<br />

CD3. It may be used therapeutically to diminish T cell<br />

reactivity in organ allotransplant recipients experiencing<br />

O

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!